Carlsmed
Carlsmed is a commercial-stage medical technology company that develops the AI-enabled aprevo platform of patient-specific 3D-printed interbody implants and surgical planning software for lumbar and cervical spine fusion, serving spine surgeons and hospitals in the United States.
- Company typePublic
- Founded2018
- HeadquartersCarlsbad, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Carlsmed does
Carlsmed, Inc. (Nasdaq: CARL) is a commercial-stage medical technology company headquartered in Carlsbad, California, founded in 2018 by Mike Cordonnier and Niall Casey. The company develops the aprevo Technology Platform, an AI-enabled end-to-end system for personalized spine fusion surgery that combines AI-driven 3D surgical planning, patient-specific 3D-printed interbody implants, and post-operative analytics. The platform supports multiple surgical approaches across lumbar indications (ALIF, LLIF, TLIF-O, TLIF-C, TLIF-CA, and bi-lateral posterior) and cervical indications (ACDF, ACDF-X), with the corra Cervical Plating System extending the portfolio into patient-specific fixation and the myaprevo iOS app providing surgeons and OR staff with 3D plan and device visualizations.
The company sells FDA-cleared personalized interbody devices directly to spine surgeons and hospitals through an enterprise field sales motion. Reimbursement is facilitated by two FDA Breakthrough Device Designations and CMS NTAP add-on payments for both lumbar and cervical procedures, with cervical NTAP providing up to approximately $21,000 in additional reimbursement per case. Carlsmed monetizes through per-procedure hardware sales at high gross margins (77.1% in Q1 2026) and is supported by the COMPASS Registry, a multi-center observational study that feeds a proprietary outcomes database of more than 500 patients into the AI planning algorithm. The company completed its IPO on Nasdaq in July 2025, raising approximately $100.5 million, and as of December 2025 employed 127 people.
Carlsmed firmographics
Firmographics- Name
- Carlsmed
- Legal name
- Carlsmed, Inc.
- Website
- https://carlsmed.com
- Company type
- Public
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Carlsmed is a commercial-stage medical technology company that develops the AI-enabled aprevo platform of patient-specific 3D-printed interbody implants and surgical planning software for lumbar and cervical spine fusion, serving spine surgeons and hospitals in the United States.
- Ownership category
- akta.pro rank
Carlsmed industry classification
Industry- Product category
- Spinal Implants
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)
- akta.pro secondary industries
- 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Spine (Orthopedic Spine) (HLAKALAE)
Keywords
Where Carlsmed is headquartered
LocationHeadquarters
- HQ city
- Carlsbad
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Carlsmed business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- aprevo Personalized Spine Surgery Devices: Sale of patient-specific 3D printed interbody implants and cervical plating systems to hospitals and surgeons for spine fusion procedures. Revenue generated through direct commercial sales to healthcare providers. Growth driven by expansion of surgeon user base and increased procedure volume.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Reimbursement-driven pricing through Medicare/Medicaid |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Carlsmed product offering
Product offeringCore offering
Carlsmed designs, manufactures, and sells the aprevo® personalized spine surgery platform, which pairs AI-enabled 3D surgical planning with patient-specific 3D-printed lumbar and cervical interbody implants (and the corra™ cervical plating system), delivered sterile to hospitals for use by spine surgeons in fusion procedures. The myaprevo® app supports case review, device design approval, and digital production tracking for the surgical team.
Product overview
Carlsmed offers the aprevo® Technology Platform, a unified AI-enabled personalized spine surgery ecosystem. The core platform encompasses aprevo® Lumbar and Cervical Interbody Systems (FDA-cleared, 3D-printed patient-specific implants) along with the corra™ Cervical Plating System. Supporting the surgical workflow is the myaprevo® 3D visualization app. The platform supports multiple surgical approaches: lumbar procedures (ALIF, ALIF-X, LLIF, TLIF-O, TLIF-C, TLIF-CA, and bilateral posterior) and cervical procedures (ACDF, ACDF-X), all designed to reduce postoperative complications and revision surgeries through customized implants tailored to individual patient anatomy.
Differentiator
Problem solved
Functional benefit
Products and services
- aprevo® Technology Platform
- aprevo® Lumbar Interbody System FDA-cleared personalized lumbar interbody devices 3D-printed to match individual patient anatomy, supporting multiple surgical approaches including ALIF, LLIF, TLIF-O, TLIF-C, TLIF-CA, and bilateral posterior procedures. Used by spine surgeons for lumbar fusion.
- aprevo® Cervical Interbody System FDA-cleared personalized cervical interbody devices for ACDF and ACDF-X procedures, 3D-printed to match each patient's cervical anatomy and designed to improve outcomes in cervical spine fusion. Used by spine surgeons at hospitals.
- corra™ Cervical Plating System Patient-specific cervical plating system that complements aprevo cervical interbody devices to provide a comprehensive personalized cervical fusion solution. Used by spine surgeons performing cervical fusion procedures.
- myaprevo® 3D Visualization App iOS app providing surgeons and OR staff with intuitive 3D visualizations of each patient-specific surgical plan and aprevo device, enabling real-time case review, device design approval, and tracking of digital production progress.
Quantifiable outcome
- 74% reduction in mechanical complication-related reoperation rates (4.3% vs 16.6%) at 2 years
- +6 more outcomes
Companies that use Carlsmed
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles1 record
Carlsmed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
Carlsmed partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- EvoNexusminorSan Diego-based nonprofit startup incubator that supported Carlsmed through its early growth stages. Carlsmed debuted on Nasdaq as one of four companies from the EvoNexus portfolio to go public in 2025.
Scale indicators12 records
Recent moves8 records
Expansion highlights6 records
Carlsmed competitors and assessment
Company assessmentDirect peers
- Alphatec Spine (ATEC): Public, spine-focused surgical implant company developing surgeon-driven lateral and procedural solutions for adult spinal deformity and degenerative conditions — directly comparable in surgeon customer profile and procedural focus.
- Globus Medical: Largest pure-play spine company in the U.S. following its merger with NuVasive. Competes head-on in lumbar and cervical interbody fusion and has invested in patient-specific and 3D-printed implant technologies.
- Mighty Oak Medical: Spine-focused company offering patient-specific 3D-printed cervical and thoracic interbody technology (ALIGN platform) — one of the closest direct comparables in personalized cervical spine fusion.
Emerging players
- SI-BONE: Public, specialty spine company (sacroiliac joint dysfunction) with similar commercial model of training surgeons on a differentiated procedural solution and building outcomes evidence to support adoption.
- 4WEB Medical: Privately held pioneer in 3D-printed orthopedic implants with an established spine interbody franchise — directly comparable in core technology (patient-specific 3D-printed titanium) but operating at a smaller commercial scale.
- Nexxt Spine: Privately held spine company with 3D-printed titanium interbody portfolio across cervical and lumbar — comparable technology approach and mid-sized commercial footprint.
- Xtant Medical: Small-cap spine hardware and biologics company with cervical and lumbar fixation products, competing for similar hospital and ambulatory surgery center accounts.
Broad incumbents
- Stryker: Diversified medtech incumbent with a substantial spine business (Tritanium 3D-printed interbodies, acquired K2M) that competes in both lumbar and cervical fusion and benefits from large salesforce and hospital contracts.
- Orthofix Medical: Spine and orthopedics company with cervical and lumbar fusion hardware plus biologics; competes in the same hospital channels as Carlsmed, albeit with a less differentiated, non-3D-printed core portfolio.
- Medtronic: Global spine market leader (post Mazor robotics acquisition) with broad cervical and lumbar fusion portfolios including patient-specific offerings and active development of personalized implant platforms.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Carlsmed social profiles
Digital presenceCarlsmed compliance and trust
Trust signalCompliance1 record
Carlsmed financial estimates
Financial estimateRevenue estimate
Valuation estimate
Carlsmed leadership team
Management profileNumber of profiles
Profiles10 records
Carlsmed funding detail
Funding detailFunding overview
Funding rounds7 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Carlsmed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Carlsmed
What does Carlsmed do?
Carlsmed designs, manufactures, and sells the aprevo® personalized spine surgery platform, which pairs AI-enabled 3D surgical planning with patient-specific 3D-printed lumbar and cervical interbody implants (and the corra™ cervical plating system), delivered sterile to hospitals for use by spine surgeons in fusion procedures. The myaprevo® app supports case review, device design approval, and digital production tracking for the surgical team.
Is Carlsmed a public or private company?
Carlsmed is a public company. It is classified as public and is currently operating.
When was Carlsmed founded?
Carlsmed was founded in 2018. It employs 101 to 250 people.
Where is Carlsmed based?
Carlsmed is headquartered in Carlsbad, United States, in the North America region.
How does Carlsmed make money?
One revenue line is on record: aprevo Personalized Spine Surgery Devices.
Who are Carlsmed's main competitors?
Direct peers on record are Alphatec Spine (ATEC), Globus Medical and Mighty Oak Medical. Emerging players are SI-BONE, 4WEB Medical, Nexxt Spine and Xtant Medical. Broad incumbents are Stryker, Orthofix Medical and Medtronic.
Does Carlsmed have an API?
No public API is recorded for Carlsmed.
What industry is Carlsmed in?
Carlsmed's product category is Spinal Implants. Its primary akta.pro industry code is HLAHAEAC, Spine Implants & Motion Preservation (Fusion/Disc/Interspinous), with a secondary code of HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3842.